# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 30


In regulation 41 (amendment of regulation 45F (provision of information)), for the inserted sub-paragraph (b) substitute—
“(b) in the case of a broker in—
(i) Great Britain, either—
(aa) the UK marketing authorisation holder, or
(bb) where applicable, the holder of the licence or authorisation granted by an appropriate authority responsible for the licensing of medicinal products in an approved country for import, or
(ii) Northern Ireland, either—
(aa) the UK marketing authorisation holder, or
(bb) where applicable, the EU marketing authorisation holder,”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/30 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-30
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.